VisionGate Presents at the World Conference on Lung Cancer for 2015 in Denver:Blinded Clinical Study of the LuCED® Test for Detection of Early Stage Lung Cancer
Company Presents Blinded Trial Data at WCLC 2015 Demonstrating that Its Non-Invasive Test Detects Early Lung Cancer PHOENIX, Ariz. (Sept. 8, 2015) – VisionGate, Inc., a next generation biotech company that has developed [...]